top of page
HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Prioritize the review of Pediatric Study Plans (PSPs) and Paediatric Investigation Plans (PIPs) for paediatric ARVs on the list of PADO priority products over lower priority drugs.
SRAs
Prioritize the review of Pediatric Study Plans (PSPs) and Paediatric Investigation Plans (PIPs) for paediatric ARVs on the list of PADO priority products over lower priority drugs.
SRAs
-
-
Develop more effective ways to prioritize PADO products within current legal frameworks
-
GAP-f members developing proposals to communicate to FDA and EMA
-
-
-
-
-
Sub-Actions & Milestones
Updates
Notes
Responsible
bottom of page